Healthcare Staff can Maximize the Value of AI with High Performing Endpoints
Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in…
Healthcare Staff can Maximize the Value of AI with High Performing Endpoints
Whether AI-driven or legacy applications, the endpoint is the decisive moment. As AI increases in use, having hardware and software that supports a high-performance experience for all staff will improve operational efficiency, patient outcomes, and revenue. The post Healthcare Staff can Maximize the Value of AI with High Performing Endpoints appeared first on MedCity News.
Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate
Here are five things providers should know about concussions. The post Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate appeared first on MedCity News.
Health Care Technology And Tactics For Addressing Gaps In Patient Communication
[Sponsored] Giving patients all the information they need to make informed decisions is crucial. However, common challenges often keep medical teams from achieving that. The post Health Care Technology And Tactics For Addressing Gaps In Patient Communication appeared first on MedCity News.
States Pay Deloitte, Others Millions To Comply With Trump Law To Cut Medicaid Rolls
States are paying contractors such as Deloitte, Accenture, and Optum millions of dollars to help them comply with the One Big Beautiful Bill Act — a law that will strip safety-net health and food benefits from millions. State governments rely on such companies to design and operate computer systems that assess whether low-income people qualify…
Trump’s Hunt for Undocumented Medicaid Enrollees Yields Few Violators
Last August, as part of the federal government’s crackdown on people in the country illegally, the Trump administration sent states the names of hundreds of thousands of Medicaid enrollees with orders to determine whether they were ineligible based on immigration status. But seven months later, findings from five states shared with KFF Health News show…
Healthcare’s Quiet Dependence on the “Possimpible”
By GANESH ASAITHAMBI In an episode of the sitcom How I Met Your Mother (HIMYM), Barney Stinson introduces a fictional word: possimpible. The possimpible combines “possible” and “impossible” and describes the extraordinary achievements by people who refuse to accept conventional limits. In modern healthcare, the possimpible is no longer a joke; it has quietly become…
How did China become a global leader in life sciences?
An NBER working paper by Barwick, Xia and Xia (2026) provides the answer: In 2010, China accounted for less than 8% of global clinical trials; by 2020, it had surpassed the US in annual registered clinical trial volume…We provide strong evidence that China’s rise was primarily driven by the National Reimbursement Drug List (NRDL) reform,…
How Mass General Brigham Decides Which AI Tools Are Worth Scaling
Mass General Brigham evaluates AI tools by carefully monitoring real-world performance before scaling them system-wide. At HIMSS earlier this month, Rebecca Mishuris, the health system’s chief health information officer and vice president of digital, explained what this process looks like. The post How Mass General Brigham Decides Which AI Tools Are Worth Scaling appeared first…
State Mitigation Strategies Could Blunt Medicaid Coverage Losses
An Urban Institute report finds that the One Big Beautiful Bill Act could cause 5–10 million people to lose Medicaid coverage by 2028, with outcomes heavily dependent on how states implement work requirements and eligibility rules. The post State Mitigation Strategies Could Blunt Medicaid Coverage Losses appeared first on MedCity News.
Kailera Plans IPO for Obesity Drug That Could Top Lilly’s Zepbound
Kailera Therapeutics’ planned IPO will fund ongoing clinical development of a pipeline led by a drug that could rival Eli Lilly’s Zepbound in both efficacy and tolerability. Meanwhile, Renaissance Capital’s recap of first quarter 2026 IPOs shows slowing activity amid market turbulence from tariffs and war. The post Kailera Plans IPO for Obesity Drug That…
